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Background: Cardiopulmonary exercise testing measures oxygen uptake at increasing levels of work and predicts
cardiopulmonary performance under conditions of stress, such as after abdominal surgery. Dynamic assessment of
preoperative exercise capacity may be a useful predictor of postoperative prognosis. This study examined the
relationship between preoperative exercise capacity and event-free survival in hepatocellular carcinoma (HCC)
patients with chronic liver injury who underwent hepatectomy.
Methods: Sixty-one HCC patients underwent preoperative cardiopulmonary exercise testing to determine their
anaerobic threshold (AT). The AT was defined as the break point between carbon dioxide production and oxygen
consumption per unit of time (VO2). Postoperative events including recurrence of HCC, death, liver failure, and
complications of cirrhosis were recorded. Univariate and multivariate analyses were performed to evaluate
associations between 35 clinical factors and outcomes, and identify independent prognostic indicators of event-free
survival and maintenance of Child-Pugh class.
Results: Multivariate analyses identified preoperative branched-chain amino acid/tyrosine ratio (BTR) <5, alanine
aminotransferase level ≥42 IU/l, and AT VO2 <11.5 ml/min/kg as independent prognostic indicators of event-free
survival. AT VO2 <11.5 ml/min/kg and BTR <5 were identified as independent prognostic indicators of maintenance
of Child-Pugh class.
Conclusions: This study identified preoperative exercise capacity as an independent prognostic indicator of event-free
survival and maintenance of Child-Pugh class in HCC patients with chronic liver injury undergoing hepatectomy.
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Major surgery has been shown to increase oxygen demand
by about 40%, which may place severe stress on cardiopul-
monary reserve [1]. Patients with high cardiopulmonary
risk have traditionally been assessed using tests such as
transthoracic echocardiography, dobutamine stress echo-
cardiography, radionuclide ventriculography, and spirom-
etry. However, these assessments have not been validated
as preoperative screening tests, and provided mostly static* Correspondence: kaibori@hirakata.kmu.ac.jp
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reproduction in any medium, provided the ormeasurements of cardiopulmonary performance [2-4].
Walking distance or ability to climb stairs have been used
as subjective measurements of exercise tolerance, and
have been shown to predict perioperative complications
[5,6]. However, these measurements lack objectivity and
do not detect silent cardiopulmonary abnormalities. Dy-
namic assessment of preoperative exercise capacity may
be a useful predictor of short- and long-term postopera-
tive prognosis. Cardiopulmonary exercise (CPX) testing
measures oxygen uptake at increasing levels of work and
predicts cardiopulmonary performance under conditions
of stress, such as after surgery. In elderly patients
undergoing major abdominal surgical procedures, the
majority of deaths from cardiopulmonary complicationsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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<11 ml/min/kg [7,8].
Hepatocellular carcinoma (HCC) is the fifth most
common cancer worldwide [9]. Maintenance of good
perioperative nutrition and metabolism may improve the
prognosis of patients with HCC undergoing hepatec-
tomy [10,11]. To date, few studies have examined the
usefulness of preoperative CPX testing in patients
undergoing hepatectomy. In the present study, we aimed
to clarify whether preoperative exercise capacity was re-
lated to event-free survival in HCC patients with chronic
liver injury undergoing hepatectomy.
Methods
Patients
HCC patients with chronic hepatitis or cirrhosis who
were scheduled for liver resection at Hirakata Hospital
of Kansai Medical University (Osaka, Japan) between
December 2008 and April 2010 were screened for inclu-
sion this study. A total of 66 HCC patients underwent
curative resection (defined as macroscopic removal of all
tumor). There was no in-patient mortality. Sixty-one of
the 66 patients were analyzed in this study, and the
other 5 were excluded because they were followed up at
other hospitals. All patients gave written informed con-
sent for participation in this study. The study protocol
was approved by the institutional ethics committee.
Cardiopulmonary exercise testing
Patients underwent preoperative CPX testing using a bi-
cycle ergometer with an incremental protocol (5.0, 7.5,
and 10 W/min). Twelve-lead electrocardiography was
used to monitor heart rate, ST segment deviation, and
arrhythmias, at rest and continuously during the exercise
and recovery periods. Blood pressure was recorded at
rest and every 2 min during the exercise and recovery
periods. Peak oxygen consumption per unit of time
(VO2) was obtained from breath-by-breath analysis of
expired air. Peak VO2 was defined as the highest mean
value during exercise when the subject could no longer
continue pedaling at 60 rpm. The AT, indicating the on-
set of metabolic acidosis, was defined as the break point
between carbon dioxide production and VO2 [12], or the
point at which the ventilatory equivalent for oxygen and
end-tidal oxygen partial pressure curves reached their
respective nadirs before beginning to increase again [13].
Thus, AT was set at the time of maximum fat combus-
tion [14]. The respiratory compensation point was set at
the point at which the ventilatory equivalent for carbon
dioxide was lowest before a systemic increase, and when
the end-tidal carbon dioxide partial pressure reached a
maximum and began to decrease [15]. Exercise was
stopped when the patient requested it because of fatigue,
pain, or headache, or if there was failure to maintain aspeed greater than 40 rpm for more than 30 seconds
despite encouragement.
Clinical variables and surgery
Before surgery, each patient underwent conventional liver
function testing and measurement of the indocyanine
green retention rate at 15 min (ICGR15). Hepatitis virus
infection screening was performed by testing for hepatitis
B surface antigen (HBsAg) and hepatitis C virus antibody
(HCVAb). Alpha-fetoprotein (AFP) and protein induced
by vitamin K absence/antagonism-II (PIVKA-II) levels
were measured in all patients. We used two methods to
determine body composition: dual-energy X-ray absorpti-
ometry (DEXA) [16] and bioelectrical impedance analysis
(BIA) [17]. Total body mass, mineral-free lean mass
(non-bone fat-free mass), fat mass, and truncal fat
were measured by whole body DEXA. BIA was performed
using the whole body 8-electrode approach with a 5-500
kHz multifrequency impedance analyzer (InBody720,
BIOSPACE Co., Ltd, Tokyo, Japan). Intracellular body
water (ICW), extracellular water (ECW), total body water
(TBW), body cell mass, and ECW ratio (ECW/TBW) were
measured.
Surgical procedures were classified according to the
Brisbane terminology proposed by Strasberg et al. [18].
Anatomic resection was defined as resection of the
tumor together with the related portal vein branches
and corresponding hepatic territory, and was classified
as hemihepatectomy (resection of half of the liver), ex-
tended hemihepatectomy (right trisectionectomy, or simi-
lar procedures on the left or for smaller resections),
sectionectomy (resection of two Couinaud sub-segments
[19]), or segmentectomy (resection of one Couinaud sub-
segment). All other procedures were classified as non-
anatomical resection, which was frequently performed for
peripheral or central tumors. Peripheral tumors and those
with extrahepatic growth were treated by partial hepatec-
tomy because this procedure achieved a sufficient surgical
margin. Central tumors located near the hepatic hilum or
major vessels were treated by enucleation only, because it
was too difficult and/or dangerous to remove enough liver
tissue to obtain adequate margins. One consultant path-
ologist reviewed all specimens for histologic confirmation
of the diagnosis. The width of the surgical margin was
measured as the distance from the tumor edge to the
resection line.
Follow-up
Peri- and postoperative complications and deaths were
recorded to determine morbidity and mortality following
hepatectomy. Postoperative complications were defined
and classified according to the modified Clavien system
[20]. Briefly, Grade I was any deviation from the normal
postoperative course that did not require special treatment,
Kaibori et al. BMC Gastroenterology 2013, 13:119 Page 3 of 9
http://www.biomedcentral.com/1471-230X/13/119Grade II required pharmacological treatment, Grade III
required surgical or radiological intervention without (IIIa)
or with (IIIb) general anesthesia, Grade IV was any life-
threatening complication involving dysfunction of one
(IVa) or multiple (IVb) major organs, and Grade V was
death. Postoperative liver-related events recorded in-
cluded recurrence of HCC, HCC-related death, post-
operative liver failure, and complications of cirrhosis
requiring hospitalization (hepatic encephalopathy, un-
controllable pleural effusion or ascites, and rupture of
esophageal or gastric varices). The Child-Pugh class
of every patient was determined preoperatively and
every 6 months postoperatively.
All surviving patients were followed up at least
every 3 months after discharge. Follow-up included
physical examination, liver function testing, chest ra-
diographs to check for pulmonary metastases, and
ultrasonography, computed tomography, or magnetic
resonance imaging to check for intrahepatic recur-
rence. Chest computed tomography was performed if
the chest radiograph showed any abnormalities. Bone
metastases were diagnosed by bone scintigraphy.
When recurrence of HCC was detected by changes
in tumor markers or on imaging, recurrence limited
to the remnant liver was treated by transarterial
chemoembolization, lipiodolization, re-resection, or
percutaneous local ablative therapy such as radiofrequency
ablation. When extrahepatic metastases were detected,
active treatment was undertaken in patients with good
hepatic functional reserve (Child-Pugh class A or B) and
good performance status (0 or 1), while other patients
were only given radiation therapy to relieve symptoms of
bone metastases. Surgical resection was undertaken in
patients with a solitary extrahepatic metastasis and no
intrahepatic recurrence.
Prognostic factors
We performed univariate and multivariate analyses of
35 clinical factors to identify independent variables
related to postoperative event-free survival and post-
operative maintenance of Child-Pugh class. The pa-
tient factors investigated were gender, age, body mass
index, alcohol abuse, HBsAg, HCVAb, non-hepatitis B
or C virus infection, diabetes mellitus, white blood
count, lymphocyte count, insulin, homeostasis model
assessment of insulin resistance, and liver function
(including albumin, total bilirubin, aspartate amino-
transferase [AST], alanine aminotransferase [ALT],
prothrombin time, cholinesterase, platelet count, alka-
line phosphatase, ICGR15, total cholesterol, low density
lipoprotein cholesterol, transferrin, transthyretin, retinol-
binding protein [RBP], transthyretin [TTR], branched
chain amino acid [BCAA]/tyrosine ratio [BTR], and
Child-Pugh class). The tumor factors investigated wereAFP and PIVKA-II. The exercise parameters investigated
were AT, VO2, and peak VO2. The body composition pa-
rameters investigated using DEXA were body mass, fat
mass, fat-free mass, and whole-body mineral density. The
body composition parameters investigated using BIA were
ICW, ECW, TBW, protein, mineral, body fat mass, and
body cell mass.
All the variables that were identified as significantly
associated with event-free survival or maintenance of
Child-Pugh class by univariate analyses were then ex-
amined using the Cox proportional hazards model to
identify variables that were independently associated
with event-free survival or maintenance of Child-Pugh
class.Statistical analysis
Continuous variables are presented as mean ± standard
deviation (SD). The significance of differences between
groups was assessed using the chi-square test or Mann–
Whitney U-test, as appropriate. The Kaplan-Meier
method was used to calculate rates of event-free survival
and maintenance of Child-Pugh class as of February
2012, and the significance of differences in survival
rates was estimated using the generalized log-rank
test. The Cox proportional hazards regression model
(stepwise method) was used for multivariate analyses.
In all analyses, p < 0.05 was considered statistically
significant.Results
This study included 61 patients (45 male, 16 female;
mean ± SD age = 70 ± 9 years). Table 1 shows the peri-
operative characteristics of HCC patients. Postoperative
complications were observed in five patients: Grade II
complications in three patients (ascites and/or pleural
effusion) and Grade IIIa complications in two patients
(intra-abdominal abscess). We followed these 61 patients
until February 2012, with a median follow-up time of
24 months (range 12-36 months). We analyzed the prog-
nostic factors associated with event-free survival and
maintenance of Child-Pugh class. Postoperative events
were defined as death due to recurrence of HCC, recur-
rence of HCC, intractable pleural effusion or ascites,
gastrointestinal bleeding, or hepatic encephalopathy.
Of the 61 patients, seven died from recurrence of
HCC, 22 developed recurrence of HCC, two developed
intractable pleural effusion or ascites, two developed
gastrointestinal bleeding, and two developed hepatic
encephalopathy.
Child-Pugh class changed from class A preoperatively to
class B postoperatively in nine patients, from class A to
class C in one patient, and from class B to class C in one
patient.
Table 1 Perioperative characteristics of HCC patients
Age (years) 70 ± 9
Gender (male/female) 45/16
HBV/HCV/NBC 12/32/15
Child-Pugh class (A/B) 56/5
Diabetes mellitus (+/−) 8/53
WBC count (/μl) 5,000 ± 1,319
Lymphocyte count (/μl) 1,484 ± 580
ICGR15 (%) 16.1 ± 7.8
Albumin (g/dl) 3.8 ± 0.4
Total bilirubin (mg/dl) 0.81 ± 0.21
Cholinesterase (U/l) 232 ± 64
Triglyceride (mg/dl) 85 ± 43
Prothrombin time (%) 92 ± 12
Platelet count (×104/μl) 15 ± 8
AST (U/l) 43 ± 27
ALT (U/l) 42 ± 28
RBP (mg/dl) 3.3 ±1.4
TTR (mg/dl) 16 ±6
BTR 5.09 ± 1.46
AFP (ng/ml) 994 ± 5,028
PIVKA-II (mAU/ml) 1,283 ± 2,209
Esophageal and/or gastric varices (+/−) 15/46
Surgical procedure (limited/anatomic) 35/26
Operation time (min) 329 ± 130
Operative blood loss (ml) 1,011 ± 1,351
Blood transfusion (+/−) 9/52
Tumor size (cm) 4.42 ± 4.09
Associated liver disease
(normal/fibrosis or hepatitis/cirrhosis) 9/30/22
Morbidity (+/−) 5/56
Data represent the mean ± standard deviation or the number of patients.
HBV hepatitis B virus, HCV hepatitis C virus, NBC non-hepatitis B or C virus,
WBC white blood cell, ICGR15 indocyanine green retention rate at 15 min;
ALT alanine aminotransferase, RBP retinol binding protein, TTR transthyretin,
BTR branched chain amino acid/tyrosine ratio, AFP α-fetoprotein, PIVKA-II
protein induced by vitamin K absence/antagonism-II.
Table 2 Results of univariate analyses of potential









HBV 13 91.7 52.1 0.1144
HCV 33 78.1 29.0
NBC 15 86.7 54.2
AST (IU/l)
≤43 30 83.3 45.6 0.1961
>43 31 82.8 28.3
ALT (IU/l)
≤42 30 93.1 53.3 0.01
>42 31 73.3 22.2
Albumin (g/dl)
≥3.8 34 87.9 51.0 0.0226
<3.8 27 76.9 11.5
RBP (mg/dl)
≥3.3 32 86.7 46.9 0.0210
<3.3 29 77.8 77.8
BTR
≥5.0 33 87.5 53.0 0.0238
<5.0 28 77.8 16.2
Platelet count (104/μl)
≥15 32 85.7 52.1 0.0355
<15 29 80.6 20.9
AT VO2 (ml/min/kg)
≥11.5 32 90.3 42.3 0.0266
<11.5 29 75.0 33.4
Peak VO2 (ml/min/kg)
≥16.5 32 87.1 50.3 0.0331
<16.5 29 78.6 10.8
Intracellular body water (l/BW kg)
≥0.33 32 90.3 35.8 0.0129
<0.33 29 75.0 30.3
Body cell mass (kg/BW kg)
≥0.47 32 90.3 34,0 0.0359
<0.47 29 75.0 33.3
Total body protein (kg/BW kg)
≥0.14 35 85.3 36.3 0.1071
<0.14 26 78.3 32.2
HBV hepatitis B virus, HCV hepatitis C virus, NBC non-hepatitis B or C virus,
AST aspartate aminotransferase, ALT alanine aminotransferase, RBP retinol
binding protein, BTR branched chain amino acid/tyrosine ratio, AT anaerobic
threshold, VO2 oxygen consumption, BW body weight.
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maintenance of child-pugh class
The preoperative factors significantly associated with
event-free survival on univariate analyses were pre-
operative ALT, albumin, RBP, BTR, platelet count, AT
VO2, peak VO2, ICW, body cell mass, and total body
protein (Table 2). The preoperative factors associated
with maintenance of Child-Pugh class on univariate
analyses were albumin, BTR, triglyceride, and AT
VO2. Multivariate analyses (Cox proportional hazards
model) of the factors associated with event-free sur-
vival on univariate analyses identified preoperativeBTR <5, ALT ≥42 IU/l, and AT VO2 <11.5 ml/min/kg
as independent prognostic indicators of event-free sur-
vival (Table 3). Multivariate analyses (Cox proportional
Table 3 Results of multivariate analyses of potential
prognostic factors for event-free survival in patients
with HCC
Variable Coefficient SE Relative risk p value
BTR (≥5 vs. < 5) 1.240 0.415 3.454 0.0028
ALT (≥42 vs. < 42 IU/l) 1.045 0.418 2.841 0.0124
AT VO2 (≥11.5 vs.
< 11.5 ml/min/kg)
1.004 0.412 2.730 0.0148
SE standard error, BTR branched chain amino acid/tyrosine ratio, ALT alanine
aminotransferase, AT anaerobic threshold, VO2 oxygen consumption.
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of Child-Pugh class on univariate analyses identified
preoperative AT VO2 <11.5 ml/min/kg and BTR <5 as
independent prognostic indicators of maintenance of
Child-Pugh class.
Figure 1 shows that there was a significant correlation
between BTR and AT VO2 in HCC patients (r = 0.410,
Y = 8.139 + 0.583 * X, p = 0.0019).
Outcomes
There was a significant difference in the event-free sur-
vival rate between patients with preoperative BTR ≥5.0
and <5.0 (p = 0.0238) (Figure 2A). There was also a sig-
nificant difference in the rate of maintenance of Child-
Pugh class between patients with preoperative BTR ≥5.0
and <5.0 (p = 0.0494) (Figure 2B).
There was a significant difference in the event-
free survival rate between patients with AT VO2
≥11.5 and <11.5 ml/min/kg (p = 0.0266) (Figure 3A).
There was also a significant difference in the rate
of maintenance of Child-Pugh class between patients
with AT VO2 ≥11.5 and <11.5 ml/min/kg (p = 0.0464)
(Figure 3B).Figure 1 Relationships between preoperative BTR and AT VO2
in HCC patients. There was a significant correlation between BTR
and AT VO2 (r = 0.410, Y = 8.139 + 0.583 * X, p = 0.0019). BTR
branched chain amino acid/tyrosine ratio, AT VO2 anaerobic
threshold oxygen consumption.Discussion and conclusions
We examined the relationships among preoperative CPX
parameters, postoperative events including recurrence of
HCC, and change in Child-Pugh class in 61 patients
undergoing hepatectomy. The variables derived from
CPX testing included peak VO2, which is the maximum
oxygen uptake at peak exercise. Previous studies indi-
cated that peak VO2 was the most useful predictor of
postoperative cardiopulmonary complications in patients
undergoing radical esophagectomy with three-field
lymphadenectomy [21] and patients undergoing surgical
procedures for lung cancer [22-26]. The AT is defined as
the point during exercise at which oxygen demand out-
strips oxygen delivery and metabolism starts to become
anaerobic. AT is a measure of the ability of the cardio-
pulmonary system to deliver adequate oxygen to tissues,
and has the advantage of being independent of patient
motivation. Reaching AT does not require high levels of
physical stress and occurs well before peak VO2 [27].
The usefulness of measuring AT has been assessed pre-
dominantly in elderly patients undergoing major surgical
procedures, allowing the development of an operative
risk grading and treatment protocol [7,8]. An AT cut-off
of 11 ml/min/kg, which is internationally recognized, is
currently used to select patients for enhanced recovery
programs after colorectal surgery. However, AT has not
been found to be useful in the assessment of cardiopul-
monary fitness of patients undergoing esophagectomy
only [21].
This study identified AT VO2 <11.5 ml/min/kg as an
independent prognostic indicator of both event-free sur-
vival and maintenance of Child-Pugh class, indicating
that CPX testing can be used to prospectively evaluate
the cardiopulmonary function of HCC patients with
chronic liver injury undergoing hepatectomy. It is pos-
sible that CPX testing can be used to predict postopera-
tive recurrence of HCC or liver dysfunction. It has
recently been reported that hepatic impairment, particu-
larly cirrhosis, leads to secondary insulin resistance and
hyperinsulinemia, resulting in the promotion of carcino-
genesis. Management of insulin resistance is therefore
critical in patients with chronic liver disease, to protect
liver function and prevent hepatocarcinogenesis. Alter-
ations in glucose metabolism also affect fat metabolism
(production of lipid peroxide and reactive oxygen spe-
cies) [28,29], which in turn may damage hepatocytes
[30], leading to possible development of HCC [31]. It is
difficult to manage insulin resistance associated with
chronic liver disease, because restriction of caloric intake
conflicts with the need to overcome malnutrition arising
from hepatocellular damage. However, a reduction in
body weight with exercise has been reported to be
advantageous in obese patients with chronic liver dis-
ease [32]. The results of these studies and of our
Figure 2 Comparisons of event-free survival and maintenance of Child-Pugh class after hepatectomy between patients with
preoperative BTR ≥5.0 and <5.0. (A) Event-free survival. The survival rate was significantly higher in patients with preoperative BTR ≥5.0
(solid line) than BTR <5.0 (dotted line) (p = 0.0238). (B) Maintenance of Child-Pugh class. The rate of maintenance of Child-Pugh class was
significantly higher in patients with preoperative BTR ≥5.0 (solid line) than BTR <5.0 (dotted line) (p = 0.0494). The numbers of patients at risk are
shown below each graph. BTR branched chain amino acid/tyrosine ratio.
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Figure 3 Comparisons of event-free survival and maintenance of Child-Pugh class after hepatectomy between patients with
preoperative AT VO2 ≥11.5 ml/min/kg and <11.5 ml/min/kg. (A) Event-free survival. The survival rate was significantly higher in patients with
preoperative AT VO2 ≥11.5 ml/min/kg (solid line) than AT VO2 <11.5 ml/min/kg (dotted line) (p = 0.0266). (B) Maintenance of Child-Pugh class.
The rate of maintenance of Child-Pugh class was significantly higher in patients with preoperative AT VO2 ≥11.5 ml/min/kg (solid line) than AT
VO2 <11.5 ml/min/kg (dotted line) (p = 0.0464). The numbers of patients at risk are shown below each graph. AT VO2 anaerobic threshold
oxygen consumption.
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cirrhosis can be safely performed in patients with AT
VO2 ≥11.5 ml/min/kg.
When liver function is impaired, metabolism of amino
acids is also impaired. Consumption of BCAAs in skel-
etal muscle is increased to compensate for the lack of
energy production by the liver [33], and aromatic amino
acids (AAAs) are abundant. The balance of BCAAs and
AAAs is known as the Fischer ratio [34]. The tyrosine
level alone can be used instead of the AAA level todetermine BTR [33]. BTR decreases in patients with liver
dysfunction, such as chronic hepatitis or cirrhosis
[35-37]. BTR can therefore be used as a marker of liver
function in patients with liver disease [33,35-37]. BTR
also has a high degree of correlation with other markers
of liver function [36,37]. In the present study, we found
that BTR was an independent prognostic indicator of
recurrence of HCC or progressive liver dysfunction.
Prolonged BCAA supplementation can therefore improve
the prognosis of HCC patients who have undergone
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operative BTR when planning perioperative care. We
found a significant correlation between BTR and AT VO2
in HCC patients.
In conclusion, preoperative exercise capacity and BTR
were identified as independent prognostic indicators of
event-free survival and maintenance of Child-Pugh class
in HCC patients with chronic liver injury undergoing
hepatectomy. These results suggest that pre- and post-
operative intervention with exercise therapy and BCAA
supplementation may be beneficial in patients with
chronic liver injury.
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